Literature DB >> 7681743

Respiratory syncytial virus.

O Ruuskanen1, P L Ogra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7681743      PMCID： PMC7131133          DOI： 10.1016/0045-9380(93)90003-u

Source DB:  PubMed          Journal:  Curr Probl Pediatr        ISSN： 0045-9380


× No keyword cloud information.
  276 in total

1.  State of the art: bronchiolitis.

Authors:  M E Wohl; V Chernick
Journal:  Am Rev Respir Dis       Date:  1978-10

2.  Humanised monoclonal antibody to respiratory syncytial virus.

Authors:  G Taylor; J Furze; P R Tempest; P Bremner; F J Carr; W J Harris
Journal:  Lancet       Date:  1991-06-08       Impact factor: 79.321

3.  Detection of respiratory syncytial virus antigen in nasal washings by Abbott TestPack enzyme immunoassay.

Authors:  C G Wren; B J Bate; H B Masters; B A Lauer
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis.

Authors:  K H Carlsen; J Leegaard; S Larsen; I Orstavik
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

5.  Atypical neonatal respiratory syncytial virus infection.

Authors:  A Unger; L Tapia; L L Minnich; C G Ray
Journal:  J Pediatr       Date:  1982-05       Impact factor: 4.406

6.  Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma.

Authors:  T Haahtela; M Järvinen; T Kava; K Kiviranta; S Koskinen; K Lehtonen; K Nikander; T Persson; K Reinikainen; O Selroos
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

7.  Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus.

Authors:  C L Lamprecht; H E Krause; M A Mufson
Journal:  J Infect Dis       Date:  1976-09       Impact factor: 5.226

8.  Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions.

Authors:  J M Leclair; J Freeman; B F Sullivan; C M Crowley; D A Goldmann
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

9.  Day-care center attendance and hospitalization for lower respiratory tract illness.

Authors:  L J Anderson; R A Parker; R A Strikas; J A Farrar; E J Gangarosa; H L Keyserling; R K Sikes
Journal:  Pediatrics       Date:  1988-09       Impact factor: 7.124

10.  Inhaled budesonide for treatment of recurrent wheezing in early childhood.

Authors:  H Bisgaard; S L Munck; J P Nielsen; W Petersen; S V Ohlsson
Journal:  Lancet       Date:  1990-09-15       Impact factor: 79.321
View more
  37 in total

Review 1.  Evidence based treatment of bronchiolitis.

Authors:  G R Sethi; Gaurav Nagar
Journal:  Indian J Pediatr       Date:  2004-08       Impact factor: 1.967

2.  Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.

Authors:  T Heikkinen; H Valkonen; L Lehtonen; R Vainionpää; O Ruuskanen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

3.  Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.

Authors:  Mohammad Jamaluddin; Sanjeev Choudhary; Shaofei Wang; Antonella Casola; Ruksana Huda; Roberto P Garofalo; Sutapa Ray; Allan R Brasier
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses.

Authors:  Terho Heikkinen; Jane Marttila; Aimo A Salmi; Olli Ruuskanen
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Lower airway disease caused by respiratory syncytial virus.

Authors:  R Aggarwal
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

6.  Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus.

Authors:  A Casola; R P Garofalo; H Haeberle; T F Elliott; R Lin; M Jamaluddin; A R Brasier
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype.

Authors:  Alicia Arnott; Sirenda Vong; Sek Mardy; Simon Chu; Monica Naughtin; Ly Sovann; Carole Buecher; Julien Beauté; Sareth Rith; Laurence Borand; Nima Asgari; Roger Frutos; Bertrand Guillard; Sok Touch; Vincent Deubel; Philippe Buchy
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

Review 8.  Bronchiolitis. Origins and optimal management.

Authors:  M L Everard
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

9.  Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007.

Authors:  Janine Reiche; Brunhilde Schweiger
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

10.  Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells.

Authors:  M Jamaluddin; R Garofalo; P L Ogra; A R Brasier
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.